4//SEC Filing
SFM PARTICIPATION LP 4
Accession 0000950142-04-004310
CIK 0001028205other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 16, 8:55 AM ET
Size
27.0 KB
Accession
0000950142-04-004310
Insider Transaction Report
Form 4
PERSEUS SOROS PARTNERS LLC
10% OwnerOther
Transactions
- Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Other
Common Stock
2004-12-13−1,500,000→ 375,044 total
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP
10% OwnerOther
Transactions
- Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
SOROS FUND MANAGEMENT LLC
10% OwnerOther
Transactions
- Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying)
SFM PARTICIPATION LP
10% OwnerOther
Transactions
- Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
SFM AH LLC
10% OwnerOther
Transactions
- Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
PEARL FRANK H
10% OwnerOther
Transactions
- Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total - Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying)
PERSEUS BIOTECH FUND PARTNERS LLC
10% OwnerOther
Transactions
- Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
SOROS GEORGE
10% OwnerOther
Transactions
- Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total - Other
Common Stock
2004-12-13−1,500,000→ 375,044 total
PERSEUSPUR LLC
10% OwnerOther
Transactions
- Other
Common Stock
2004-12-13−1,500,000→ 375,044 total - Conversion
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total→ Common Stock (1,500,000 underlying) - Conversion
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
Footnotes (6)
- [F1]All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"). Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseus EC, L.L.C., a Delaware limited liability company ("Perseus EC"), is the managing member of Perseus Partners. Perseuspur, LLC, a Delaware limited liability company ("Perseuspur"), is a member of Perseus EC. Perseus-Soros Partners may be deemed to indirectly beneficially own the 375,044 shares directly beneficially owned by Perseus-Soros and to directly beneficially own the 76,682 shares distributed to it.
- [F2]Each of the reporting persons other than Perseus-Soros and Perseus-Soros Partners may be deemed to indirectly beneficially own the 375,044 shares directly beneficially owned by Perseus-Soros and the 76,682 shares directly beneficially owned by Perseus-Soros Partners.
- [F3]SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation.
- [F4]On December 13, 2004, Perseus-Soros converted 750,000 shares of the Issuer's Series A Convertible Participating Preferred Stock ("Series A Preferred Stock") into 1,500,000 shares of common stock at a ratio of 2.0 shares of Common Stock for each share of Series A Preferred Stock. On that same date, Perseus-Soros distributed 1,500,000 shares of the Issuer's Common Stock to its partners in a pro rata distribution, including 76,682 shares of the Issuer's Common Stock to Perseus-Soros Partners, LLC, the sole general partner of Perseus-Soros. No consideration was paid in connection with this distribution.
- [F5]Shares of Series A Preferred Stock are convertible into shares of common stock from the date of issuance, May 8, 2002, and any time thereafter. The Conversion Price of Series A Preferred Stock is equal to $1.50 per share of Common Stock, subject to adjustment upon the occurrence of certain events set forth in the Certificate of Designations for the Series A Preferred Stock. The number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock will be such number equal to the quotient obtained from dividing the then applicable Liquidation Amount of the share of Series A Preferred Stock by the then applicable Conversion Price. No consideration was paid by Perseus-Soros with respect to the conversion of the Series A Preferred Stock.
- [F6]Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), Perseus-Soros Partners, Perseus Partners, SFM Participation, Perseus EC, Perseuspur, SFM AH, Frank H. Pearl, Soros Fund Management LLC and George Soros are deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of Perseus-Soros. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that Perseus-Soros Partners, Perseus Partners, SFM Participation, Perseus EC, Perseuspur, SFM AH, Frank H. Pearl, Soros Fund Management LLC or George Soros is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros in excess of such amount.
Documents
Issuer
BIOENVISION INC
CIK 0001028205
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001253598
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 16, 8:55 AM ET
- Size
- 27.0 KB